---
title: "Aromatase Inhibitors: When and How to Use Them"
description: "AIs explained: dose by estradiol, avoid the E2 crash, Arimidex vs Aromasin, how to titrate from bloods."
lang: en
dateModified: 2026-05-23
canonical: https://anaprotokol.com/en/guides/aromatase-inhibitors-on-cycle
---

# Aromatase Inhibitors: When and How to Use Them

**Aromatase inhibitors (AIs)** are the most badly used tools in cycle pharmacology. Too often taken prophylactically 'just to be safe', they flip a user from an estrogen-too-high problem to an estrogen-crashed problem — which is neither more comfortable nor healthier. Used well, on the other hand, they keep estradiol inside a target range and head off serious estrogenic complications.

This guide explains the real role of AIs, the reasoned protocols built on blood work, the practical differences between [anastrozole (Arimidex / Adex)](/en/molecule/anastrozole) and [exemestane (Aromasin)](/en/molecule/exemestane), and what happens when you take too much. It sits inside the [side effects and management](/en/guides/steroid-side-effects-guide) cluster.

## What an aromatase inhibitor actually does

Aromatase is the enzyme that converts testosterone (and certain aromatizing anabolic steroids like [Dianabol](/en/molecule/dianabol) and [Anadrol](/en/molecule/anadrol)) into estradiol — the main estrogenic hormone. Under exogenous gear at higher doses, aromatization produces estradiol levels well above physiological values. Past a threshold, the estrogenic side effects show up: gyno, water retention, hypertension, mood instability.

An AI blocks that enzyme and brings estradiol production back down. The consensus target for men on cycle is 20 to 40 pg/mL — not more, not less [1] [2]. That is the range where the physiological benefits of estradiol (libido, joint lubrication, HDL, mood, bone density) stay intact while you avoid the bad effects of an excess.

> Estradiol is not an 'enemy to be eliminated'. It is a hormone necessary to male well-being, including on cycle. The goal of an AI is never to crush estradiol to zero — it is to hold it in a useful range.

## When to bring in an AI: bloods first

The modern approach, more cautious than what you saw in the 2010s, is to not start an AI prophylactically [5] [6]. Individual sensitivity to aromatization varies massively; two users on the same cycle can run very different estradiols. Setting the dose blind is flying without instruments.

### The recommended protocol

1. Baseline estradiol before the cycle, as part of the [baseline blood panel](/en/guides/blood-work-on-cycle).
2. No AI at the start of the cycle.
3. Mid-cycle bloods (estradiol + clinical signs) at week 4 to 6.
4. If estradiol > 50–60 pg/mL AND estrogenic signs: bring in an AI at a low dose (anastrozole 0.25 mg EOD, exemestane 12.5 mg EOD).
5. Re-check estradiol 2 to 3 weeks later; titrate up or down.

### Estrogenic signs to know

- Nipple sensitivity or itching (early sign of [gyno](/en/guides/gyno-from-steroids)).
- Rapid water retention, puffy face, unusual weight gain (see [water retention on cycle](/en/guides/water-retention-on-cycle)).
- BP creeping up with no other obvious cause.
- Marked mood swings or heightened emotionality.

## Dosing an AI by measured estradiol

The ranges below are indicative and reflect community practice; individual sensitivity can force very different doses [3]. It is bloods that validate the dose, not feel.

| Measured E2 | Reading | Typical action |
| --- | --- | --- |
| < 20 pg/mL | Too low (crash) | Stop the AI, wait, recheck |
| 20–40 pg/mL | Target | Hold / no AI needed |
| 40–50 pg/mL | Upper bound | Watch; introduce AI if clinical signs |
| 50–80 pg/mL | High | Low-dose AI (anastrozole 0.25–0.5 mg EOD, exemestane 12.5 mg EOD) |
| > 80 pg/mL | Very high | Standard-dose AI, fast recheck |

### Anastrozole: consensus ranges

- Low dose: 0.25 mg EOD (every other day).
- Intermediate: 0.5 mg EOD.
- Higher (aggressive cycles or users very sensitive to aromatization): 0.5 to 1 mg EOD, with a fast recheck on bloods.

### Exemestane: consensus ranges

- Low dose: 12.5 mg EOD.
- Standard: 12.5–25 mg EOD.
- Higher (rare in performance use): 25 mg daily.

## Arimidex vs Aromasin: how to choose

Both molecules hit the same goal (reduce estradiol) through two different mechanisms. That accounts for the practical nuances below.

| Criterion | Anastrozole (Arimidex) | Exemestane (Aromasin) |
| --- | --- | --- |
| Mechanism | Reversible inhibitor | Irreversible (suicide) inhibitor |
| Half-life | ≈ 48 hours | ≈ 24 hours |
| HDL impact | Tends to drop HDL | More neutral / less unfavorable |
| IGF-1 | Neutral | Slight rise |
| Own androgenic effect | None | Mild (handy on cut) |
| Rebound on stopping | Possible E2 rebound | Less rebound (irreversible binding) |

In practice: anastrozole stays the most used, the most available, the most documented [7]. Aromasin is often preferred on a cut (mild androgenic contribution, better HDL profile) and by users who notice an E2 rebound when they stop Adex. Both work — the choice is not decisive.

> [Nolvadex](/en/molecule/nolvadex) is not an aromatase inhibitor: it does not lower estradiol, it only blocks its action at breast-tissue receptors. Useful to treat starting gyno, it does not replace an AI for managing a globally elevated estradiol.

## The estradiol crash: the most underestimated risk

The E2 crash is the direct consequence of an over-dosed AI. Estradiol slides under the useful threshold (< 15–20 pg/mL) and produces its own set of side effects — often misattributed to the cycle itself [4].

- Libido collapse, erection problems despite high testosterone.
- Diffuse joint pain (knees, elbows, wrists) — estrogen contributes to joint lubrication.
- HDL tanked, lipid profile severely degraded.
- Low mood, anhedonia, irritability, sometimes frank depression.
- Persistent fatigue despite decent sleep.
- Abnormal thirst, dry skin.

> Many users read these signs as 'a testosterone problem' and push the dose higher, or push the AI higher 'just in case'. That is the scenario that makes everything worse. The absolute rule: an estradiol blood draw before changing anything. An AI goes down or stops fast; a cycle gets dialed up fast.

### Getting out of a crash

Immediate stop of the AI. Anastrozole being reversible, estradiol climbs back over days to a couple of weeks. Exemestane being irreversible, you wait for new enzyme synthesis (1 to 2 weeks typically). Recheck E2 after that window before any AI re-introduction at a lower dose.

## Special cases: progestogenic compounds and HCG

### Progestogenic compounds

[Nandrolone (deca)](/en/molecule/nandrolone-deca) and [trenbolone (tren)](/en/molecule/trenbolone-acetate) carry progestin activity. An AI alone may not be enough to prevent gyno or erectile dysfunction on deca/tren. Controlling prolactin and the possible use of a prolactin inhibitor (cabergoline) round out the management. Details in the [hormonal markers on cycle](/en/guides/hormonal-markers-on-cycle) guide.

### HCG and estradiol

HCG, by stimulating testicular Leydig cells, also increases endogenous testosterone production and therefore aromatization. A protocol running HCG alongside a cycle (to preserve testicular volume) has to account for this: estradiol can run higher than expected, and the AI gets adjusted accordingly.

## FAQ

### Why not take an AI from day one 'just in case'?

Because sensitivity to aromatization is individual, and the 'average' prophylactic dose pushes a meaningful share of users below the useful threshold right at the start. The consequences of crashed estradiol (libido, joints, HDL, mood) are as disabling as those of high estradiol — and harder to trace back to their cause. The baseline → mid-cycle → adjustment sequence is more cautious.

### Arimidex or Aromasin — which one should I run?

Both work. Adex is the default — most available, most documented in performance use. Aromasin is often preferred on a cut (mild own-androgenic effect, better HDL profile) and by users who report an E2 rebound when they stop Adex. Individual sensitivity is the deciding criterion: some users respond better to one than the other with no clean theoretical explanation.

### How long after an AI dose can I test estradiol?

Ideal is to draw away from the last dose, in a stable state (same time of day, several days after introducing or changing the dose). For anastrozole, wait 5 to 7 days after a dose change before re-checking — that is the time to reach a new serum plateau. For exemestane (irreversible action), 7 to 10 days after stopping or lowering to evaluate the rebound.